GSK logo

GSK
Glaxosmithkline plc - ADR

9,512
Mkt Cap
$114.68B
Volume
3.81M
52W High
$61.70
52W Low
$32.73
PE Ratio
15.44
GSK Fundamentals
Price
$57.37
Prev Close
$55.84
Open
$57.03
50D MA
$55.90
Beta
0.28
Avg. Volume
4.75M
EPS (Annual)
$3.72
P/B
5.23
Rev/Employee
$644,088.53
$119,635.62
Loading...
Loading...
News
all
press releases
GSK plc (LON:GSK) Receives Consensus Recommendation of "Hold" from Analysts
Shares of GSK plc (LON:GSK - Get Free Report) have been given a consensus recommendation of "Hold" by the seven brokerages that are presently covering the firm, Marketbeat.com reports. One research...
MarketBeat·16h ago
News Placeholder
More News
News Placeholder
GSK (GSK) is a Top-Ranked Value Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks·1d ago
News Placeholder
From Lungs To Nasal Polyps: Sanofi Finds Success With 2-in-1 Inflammation Blocker
Sanofi reports positive Phase 2 data for lunsekimig in asthma and nasal polyps, while atopic dermatitis study misses main goal.read more...
Benzinga·2d ago
News Placeholder
GSK (LON:GSK) Given "Buy" Rating at Jefferies Financial Group
Jefferies Financial Group restated a "buy" rating and issued a GBX 2,450 price objective on shares of GSK in a research report on Thursday...
MarketBeat·6d ago
News Placeholder
Trump Administration Prepares 100% Tariffs On Drugmakers Without Pricing Deals: Report
According to a Bloomberg report, Trump may impose 100% tariffs on drugmakers without pricing deals, as part of a broader push to lower drug costs.read more...
Benzinga·7d ago
News Placeholder
GSK PLC Sponsored ADR (NYSE:GSK) Receives Average Recommendation of "Reduce" from Analysts
Shares of GSK PLC Sponsored ADR (NYSE:GSK - Get Free Report) have received an average recommendation of "Reduce" from the eleven ratings firms that are currently covering the firm, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a sell recommendation, seven ha...
MarketBeat·7d ago
News Placeholder
Bristol Myers Squibb adding 3 medications on TrumpRx
EXCLUSIVE: Bristol Myers Squibb is launching three medications on TrumpRx.gov on Monday, FOX Business has learned.The three prescription drugs will each be offered at deep discounts that range from 40% to 90% off the retail price.The Princeton, New Jersey-based company's drug Sotyktu retails for...
FOXBusiness.com - Business/Financial·9d ago
News Placeholder
GSK Sets Up Late-Stage Readouts: Chronic Cough Phase 3 Data Near, Hep B Filing on Track
GSK (NYSE:GSK) respiratory, immunology and inflammation R&D head Kaivan Khavandi said the company is positioning several late-stage programs around clear unmet need and what he described as better "target trait pairing," highlighting upcoming chronic cough data, planned hepatitis B regulatory st...
MarketBeat·12d ago
News Placeholder
GSK (LON:GSK) Given "Hold" Rating at Berenberg Bank
Berenberg Bank restated a "hold" rating and issued a GBX 2,000 target price on shares of GSK in a research note on Thursday...
MarketBeat·14d ago
News Placeholder
GSK (LON:GSK) Receives Buy Rating from Shore Capital Group
Shore Capital Group restated a "buy" rating on shares of GSK in a report on Wednesday...
MarketBeat·15d ago
<
1
2
...
>

Latest GSK News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.